Investors Seek GLP-1 Alternatives After Nausea Hurdles
A new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Discussion of the entities and frameworks responsible for enforcing index rules and governance, including accountability and compliance checks.
28,655 articlesA new wave of weight-loss therapies aims to beat current GLP-1 drugs by reducing side effects and daily dosing. Inves...
Global markets pulled back after Iran strikes sparked a heated political response. Investors weigh consequences for s...
Tech leaders are shifting in 2026, prompting a clash between QQQ and VGT for access to Big Tech. This report breaks d...
A trio of S&P 500 dividend stocks that pay monthly dividends are outperforming the broader index, delivering reliable...
Rising buzz that Elon Musk could reach trillionaire status clashes with Tesla's 2026 stock slump. This report breaks ...
A high-profile insider sale at Urban Outfitters has investors weighing risk and opportunity. Learn how to interpret t...
Insider moves can mislead, but context matters. This article explains why Nick Khan’s 9,589 share sale isn’t a warnin...
Mastercard announces a new Virtual C-Suite to help small businesses run more efficiently. The AI suite starts with a ...
A high-profile insider move by Pinterest’s leadership drew attention from investors. This deep dive explains what the...
At ICE X26, MBA President Bob Broeksmit outlined how Trump orders, AI-driven underwriting, and tight housing supply a...
When a company director trims a stake, investors ask: what does it mean for the stock? This guide walks you through h...
Anduril CEO Brian Schimpf has quietly steered the defense-tech startup from desert days to a major defense contractor...